Literature DB >> 18448974

Current concepts in immunoregulation and pathology of human Chagas disease.

Walderez O Dutra1, Kenneth J Gollob.   

Abstract

PURPOSE OF REVIEW: Chagas disease is a complex ailment caused by infection with Trypanosoma cruzi. It afflicts millions in Latin America. Years of studies have focused on the development of pathology in Chagas disease and recent studies have helped us understand the cellular mechanisms behind differential clinical evolution of Chagas disease. RECENT
FINDINGS: We discuss recent findings concerning the cellular immune response in human Chagas disease focusing on immunoregulation and the development of pathology. We seek to put several findings into the context of a disease that initially controls an extreme and patent infection, and later progresses to a chronic phase marked by the presence (cardiac and digestive forms), or not (indeterminate form), of associated pathology.
SUMMARY: Several theories exist to explain differential clinical evolution of Chagas disease. A coherent understanding of these theories will certainly aid in determining what combination of them approximates the true development of chagasic pathology. For achieving the goal of developing a successful therapy or intervention, it is critical that no theory be excluded at this point, but. Rather, rather that a thoughtful analysis and assimilation of the best components of each system into a central theory that best fits the reality of human Chagas disease is desirable.

Entities:  

Mesh:

Year:  2008        PMID: 18448974      PMCID: PMC3322114          DOI: 10.1097/QCO.0b013e3282f88b80

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  50 in total

Review 1.  An update on the management of Chagas cardiomyopathy.

Authors:  Manoel O C Rocha; Mauro M Teixeira; Antonio L Ribeiro
Journal:  Expert Rev Anti Infect Ther       Date:  2007-08       Impact factor: 5.091

2.  Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells.

Authors:  Alexandre Barcelos Morais da Silveira; Elenice M Lemos; Sheila J Adad; Rodrigo Correa-Oliveira; John B Furness; Débora D'Avila Reis
Journal:  Hum Pathol       Date:  2007-05-08       Impact factor: 3.466

3.  Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.

Authors:  R T Gazzinelli; M E Pereira; A Romanha; G Gazzinelli; Z Brener
Journal:  Parasite Immunol       Date:  1991-07       Impact factor: 2.280

4.  Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.

Authors:  F Kierszenbaum; H M Lopez; M B Sztein
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

5.  Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil.

Authors:  Mário Steindel; Letícia Kramer Pacheco; Daniele Scholl; Marcos Soares; Milene Hoehr de Moraes; Iriane Eger; Cecília Kosmann; Thais Cristine Marques Sincero; Patrícia Hermes Stoco; Silvane Maria Fonseca Murta; Carlos José de Carvalho-Pinto; Edmundo Carlos Grisard
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-24       Impact factor: 2.803

Review 6.  Immune system recognition of Trypanosoma cruzi.

Authors:  Rick L Tarleton
Journal:  Curr Opin Immunol       Date:  2007-07-24       Impact factor: 7.486

7.  Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease.

Authors:  W O Dutra; O A Martins-Filho; J R Cançado; J C Pinto-Dias; Z Brener; G L Freeman Júnior; D G Colley; G Gazzinelli; J C Parra
Journal:  Int Immunol       Date:  1994-04       Impact factor: 4.823

8.  Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes.

Authors:  D D Reis; E M Jones; S Tostes; E R Lopes; G Gazzinelli; D G Colley; T L McCurley
Journal:  Am J Trop Med Hyg       Date:  1993-05       Impact factor: 2.345

9.  Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process.

Authors:  M de L Higuchi; P S Gutierrez; V D Aiello; S Palomino; E Bocchi; J Kalil; G Bellotti; F Pileggi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals.

Authors:  Rajendranath Ramasawmy; Kellen C Faé; Edecio Cunha-Neto; Susan C P Borba; Barbara Ianni; Charles Mady; Anna C Goldberg; Jorge Kalil
Journal:  Mol Immunol       Date:  2007-06-04       Impact factor: 4.407

View more
  43 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

4.  Circulating serum markers and QRS scar score in Chagas cardiomyopathy.

Authors:  Eva H Clark; Morgan A Marks; Robert H Gilman; Antonio B Fernandez; Thomas C Crawford; Aaron M Samuels; Alicia I Hidron; Gerson Galdos-Cardenas; Gilberto Silvio Menacho-Mendez; Ricardo W Bozo-Gutierrez; Diana L Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

5.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.

Authors:  L S A Passos; L M D Magalhães; R P Soares; A F Marques; M do C P Nunes; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2017-07-03       Impact factor: 4.330

7.  Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.

Authors:  Ana-Carolina Oliveira; Bruna C de Alencar; Fanny Tzelepis; Weberton Klezewsky; Raquel N da Silva; Fabieni S Neves; Gisele S Cavalcanti; Silvia Boscardin; Marise P Nunes; Marcelo F Santiago; Alberto Nóbrega; Maurício M Rodrigues; Maria Bellio
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection.

Authors:  Claudiney Melquíades Rodrigues; Helder Magno Silva Valadares; Amanda Fortes Francisco; Jerusa Marilda Arantes; Camila França Campos; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Márcio Sobreira Silva Araujo; Rosa Maria Esteves Arantes; Egler Chiari; Glória Regina Franco; Carlos Renato Machado; Sérgio Danilo Junho Pena; Ana Maria Caetano Faria; Andréa Mara Macedo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

Review 9.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

10.  Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.

Authors:  Rômulo Dias Novaes; Marcus Vinicius Pessoa Sartini; João Paulo Ferreira Rodrigues; Reggiani Vilela Gonçalves; Eliziária Cardoso Santos; Raquel Lopes Martins Souza; Ivo Santana Caldas
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.